These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2643222)

  • 21. Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera. Race, transplant history, and HLA-DR1 phenotype.
    Barger B; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Transplantation; 1989 Feb; 47(2):240-5. PubMed ID: 2645705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crossmatching with B and T cells and flow cytometry.
    Iwaki Y; Lau M; Cook DJ; Takemoto S; Terasaki PI
    Clin Transpl; 1986; ():277-84. PubMed ID: 3154417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
    Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
    Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of IgG-mediated complement-dependent cytotoxicity by reducing reagents.
    McIntyre JA; Boldt HD; Faulk WP; Halbrook H
    J Heart Lung Transplant; 1991; 10(1 Pt 1):117-24. PubMed ID: 2007163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quality control program for crossmatching procedures for solid organ transplantation. The participating laboratories of the Australasian and South Asian Tissue Typing Association.
    Howden AJ; Sayer DC; Bennett G; Smith LK; Christiansen FT
    Hum Immunol; 2000 Apr; 61(4):419-24. PubMed ID: 10715519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of IgM-positive crossmatches on survival in heart transplant recipients.
    Scheinin SA; Radovancević B; Kimball P; Duncan JM; Van Buren CT; Frazier OH; Kerman R
    Tex Heart Inst J; 1995; 22(1):67-71. PubMed ID: 7787472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients.
    Christiaans MH; Overhof R; ten Haaft A; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1996 Nov; 62(9):1341-7. PubMed ID: 8932282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of panel reactive antibody on live related donor kidney transplantation: Indian experience.
    Tahir MT; Mehra NK; Taneja V; Singal DP; Dash SC; Singh R; Mehta SN
    Transpl Immunol; 1994 Sep; 2(3):238-42. PubMed ID: 8000853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
    Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
    Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of IgM Antibodies as a Crucial Element of Diagnostics in Sensitized Patients Awaiting Kidney Transplant.
    Olszowska-Zaremba N; Gozdowska J; Sobierajska I; Zagożdżon R
    Transplant Proc; 2020 Oct; 52(8):2268-2272. PubMed ID: 32247595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadaver renal transplantation ignoring peak-reactive sera in patients with markedly decreasing pretransplant sensitization.
    Sanfilippo F; Vaughn WK; Spees EK; Bollinger RR
    Transplantation; 1984 Aug; 38(2):119-24. PubMed ID: 6380038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dithiothreitol treatment of crossmatch sera in highly immunized transplant recipients.
    Rudy T; Opelz G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):800-2. PubMed ID: 3274876
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching.
    Karuppan SS; Lindholm A; Möller E
    Transplantation; 1992 Mar; 53(3):666-73. PubMed ID: 1549863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful kidney transplantation with a positive IgM crossmatch.
    Spees E; McCalmon R
    Transplant Proc; 1990 Aug; 22(4):1887-8. PubMed ID: 2389473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.